Overview
Rahel Demisse is a Hematologist practicing medicine in Moreno Valley, California.
Dr. Demisse is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Gastroesophageal Junction Cancer.
She is actively involved in clinical research, co-authoring 4 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
26520 Cactus Ave, Moreno Valley, CA 92555
11234 Anderson St, Loma Linda, CA 92350
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
City Of Hope Comprehensive Cancer Center-Duarte
Stephen Forman is a Hematologist and an Oncologist practicing medicine in Duarte, California. Dr. Forman is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.
UCI Health Chao Family Comprehensive Cancer Center
"Dr. Lauren C. Pinter-Brown is a board-certified, fellowship-trained UCI hematologist-oncologist who specializes in the diagnosis and treatment of patients with lymphomas.A nationally recognized expert, Pinter-Brown has a longstanding interest in malignant lymphoma, with a particular focus on T-cell and skin lymphomas. Her clinical interests also include antiphospholipid, B-cell lymphoma, Hodgkin's lymphoma, mycosis fungoides, non-Hodgkins lymphoma, stem-cell transplant and Waldenstrom's disease.She her medical degree at the David Geffen School of Medicine at UCLA Medical School, followed by an internship and residency in internal medicine at Harbor-UCLA Medical Center. She completed a fellowship in hematology and oncology at the Keck School of Medicine at USC.A prolific clinical investigator, Pinter-Brown has made important contributions to several clinical trials that led to approval of new drugs for the treatment of T-cell lymphoma. Her research focus is on optimizing treatment options for patients with lymphoma, especially cutaneous and T-cell lymphomas. Her primary goal is to care for patients through diagnosis, treatment and beyond and to ensure that they are able ""to live their best life.""". Dr. Pinter-Brown is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Transplant. Dr. Pinter-Brown is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.
Uc Irvine Medical Center Oncology
Dr. Warren A. Chow is a board-certified UCI Health oncologist who specializes in melanoma and sarcomas. He serves as associate director for clinical services at the UCI Health Chao Family Comprehensive Cancer Center.He received his medical degree from Chicago Medical School at Rosalind Franklin University of Medicine and Science in North Chicago, Ill. He completed an internship and residency in internal medicine at Cedars-Sinai Medical Center in Los Angeles. Next he received fellowship training in medical oncology, hematology and bone marrow transplantation at the City of Hope in Duarte, Calif., where he served nearly 30 years as a clinician and researcher conducting bench-to-bedside studies in both bone and soft-tissue sarcomas.The recipient of numerous research grants from the National Cancer Institute, the U.S. Food and Drug Administration, the Melanoma Research Foundation and many others, Chow has been the principal investigator on more than three dozen clinical trials. He is the author of more than 80 publications and four book chapters, and he serves on the editorial boards of the journalsPLOS ONE,F1000 ResearchandScientific Reports (Nature). Dr. Chow is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, and Chondrosarcoma. Dr. Chow is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine - Internal Medicine.
Frequently Asked Questions about Dr. Rahel Demisse
How do I make an appointment with Dr. Rahel Demisse?
You can book an appointment with Dr. Rahel Demisse by calling their office at 951-486-4000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rahel Demisse a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rahel Demisse is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rahel Demisse specialize in?
While Dr. Rahel Demisse is a Hematology, they have specific expertise in Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), and Large-Cell Immunoblastic Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Rahel Demisse participate in research or clinical trials?
Yes. Dr. Rahel Demisse has published 4 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Rahel Demisse's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rahel Demisse accept my insurance?
Dr. Rahel Demisse accepts most major insurance plans, including Change Healthcare and Cigna. We recommend calling the office directly at 951-486-4000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Multiple MyelomaDr. Demisse isAdvanced. Learn about Multiple Myeloma.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Demisse isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Demisse isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Demisse isExperienced. Learn about Follicular Lymphoma.
- Gastroesophageal Junction CancerDr. Demisse isExperienced. Learn about Gastroesophageal Junction Cancer.
- Large-Cell Immunoblastic LymphomaDr. Demisse isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- Non-Hodgkin LymphomaDr. Demisse isExperienced. Learn about Non-Hodgkin Lymphoma.


